Radiofrequency ablation used to treat snoring patients

NewsGuard 100/100 Score

New research released at world's largest ENT meeting

Radiofrequency ablation, a procedure that uses heat to shrink the tissue of the soft palate, is an effective and minimally invasive procedure that can be used to treat patients who snore.

In a paper presented at the 2009 American Academy of Otolaryngology - Head and Neck Surgery Foundation (AAO-HNSF) Annual Meeting & OTO EXPO in San Diego, researchers discussed treatment of primary snoring in a prospective trial in a prospective study of 60 patients. They sought to assess the three-year efficacy and morbidity of combined radiofrequency of the soft palate and partial uvulectomy.

Due to its minimally invasive character, significant improvement of primary snoring (snoring without sleep apnea), and low postoperative complication rates, radiofrequency surgery of the soft palate in general has become widespread. Nevertheless, the long-term clinical efficacy of radiofrequency surgery of the soft palate in primary snoring was limited.

Compared with the preoperative snoring score, the severity of snoring was reduced after two treatment sessions of combined radiofrequency. Seventy-six percent of the patients were satisfied to receive this operative treatment, after three-year follow-up.

Primary snoring may be an early predictor for people who will eventually develop obstructive sleep apnea. In contrast to obstructive sleep apnea, no generally accepted gold standard is available for the treatment of primary snoring.

The researchers noted that prior to their study long-term research results surrounding radiofrequency surgery of primary snoring were limited. Results of the current study may be able to guide physicians and patients in choosing effective treatment options for snoring.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research pinpoints key pathways in prostate cancer's vulnerability to ferroptosis